Millennium Management
FOLD

Millennium Management’s Amicus Therapeutics FOLD Stock Holding History

Millennium Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-150,000
Closed -$1.43M – 6990
2021
Q3 		$1.43M Buy
+150,000
New +$1.53M ﹤0.01% 4287
2021
Q1 		– Sell
-151,500
Closed -$3.5M – 6106
2020
Q4 		$3.5M Buy
+151,500
New +$3.1M ﹤0.01% 2787

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Millennium Management's FOLD Position: Q1 2026 in Review

Millennium Management increased its Amicus Therapeutics (FOLD) stake by 164% in Q1 2026, buying an estimated $70.4M and bringing the position to 7,908,459 shares worth $114M. The position accounts for 0.05% of the portfolio, ranked #388.

Millennium Management first reported a position in FOLD in Q2 2014 and has held it in 39 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Millennium Management held 7,908,459 shares of Amicus Therapeutics worth $114M as of Q1 2026.
  • Millennium Management bought 4,913,370 Amicus Therapeutics shares in Q1 2026, an estimated $70.4M.
  • Amicus Therapeutics made up 0.05% of Millennium Management's portfolio in Q1 2026, its #388 holding.
  • Millennium Management first reported a position in Amicus Therapeutics in Q2 2014 and has held it in 39 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.